A Research Consortium to Define the Function of MeCP2: A Step Towards the Development of Therapeutics for Treating Rett Syndrome

Bird, Adrian (Principal Investigator)

Status	Finished
Effective start/end date	15/01/14 → 14/07/17

Funding

Non-EU-based charities: £673,484.00

1 Article

MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain
Lagger, S., Connelly, J. C., Schweikert, G., Webb, S., Selfridge, J., Ramsahoye, B. H., Yu, M., He, C., Sanguinetti, G., Sowers, L. C., Walkinshaw, M. D. & Bird, A., 12 May 2017, In: PLoS Genetics. 13, 5, 26 p., e1006793.
Research output: Contribution to journal › Article › peer-review

Open Access
File